Nuvectra to Present at the Wedbush PacGrow Healthcare Conference

PLANO, Texas, July 28, 2017 (GLOBE NEWSWIRE) -- Nuvectra Corporation NVTR, a neurostimulation medical device company, announced today that Scott Drees, Chief Executive Officer, and Walter Berger, Chief Operating Officer & Chief Financial Officer, are scheduled to present at the Wedbush PacGrow Healthcare Conference in New York, NY. Management will also be available for one-on-one meetings at the conference.

Event:       Wedbush PacGrow Healthcare Conference

Format:     Presentation and One-on-One Meetings

Date:         Wednesday, August 16, 2017

Time:        1:20 pm ET

A webcast of the Company's presentation will be available on the investor relations section of Nuvectra's website at www.nuvectramed.com. A webcast replay of the chat will be available for 90 days.

About Nuvectra Corporation

Nuvectra^TM is a neurostimulation company committed to helping physicians improve the lives of people with chronic neurological conditions. The Algovita^® Spinal Cord Stimulation (SCS) System is our first commercial offering and is CE marked and FDA approved for the treatment of chronic intractable pain of the trunk and/or limbs. Our innovative technology platform also has capabilities under development to support other indications such as sacral neuromodulation (SNM) for the treatment of overactive bladder, and deep brain stimulation (DBS) for the treatment of Parkinson's Disease. In addition, our NeuroNexus subsidiary designs, manufactures and markets leading-edge neural-interface technologies for the neuroscience clinical research market. Visit the Nuvectra website at www.nuvectramed.com.

Company Contacts:
Nuvectra Corporation

Walter Berger, COO & CFO
(214) 474-3102
wberger@nuvectramed.com

Jennifer Armstrong, Media Relations
(214) 474-3110
jarmstrong@nuvectramed.com

Investor Contacts:
The Ruth Group		

Zack Kubow
(646) 536-7020
zkubow@theruthgroup.com

Brian Johnston
(646) 536-7028
bjohnston@theruthgroup.com